Drug factory · FDA FEI 3005890633
Intas Pharmaceuticals Limited
Camp Road, Selaqui, Dehradun, India
Serious problems, FDA action at FDA's last inspection, Sep 16, 2025.
Official Action Indicated: inspectors found significant problems and FDA recommended regulatory action, such as a warning letter or import alert.
1 drug inspection on record since 2025: 0 with no problems, 0 with problems fixed voluntarily, 1 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Levothyroxine | Makes it and tests it | Accord Healthcare Inc. | 16729-447, 16729-448, 16729-449 +9 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 16, 2025 | Serious problems, FDA action | Drug Quality Assurance | — |
Registered with FDA for: analysis; manufacture; pack.